GPP

Great Point Partners Portfolio holdings

AUM $308M
1-Year Est. Return 183.85%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+183.85%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$240M
AUM Growth
+$85.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
38
New
Increased
Reduced
Closed

Top Buys

1
+$16.7M
2
+$14M
3
+$11.6M
4
NKTR icon
Nektar Therapeutics
NKTR
+$9.93M
5
DNTH icon
Dianthus Therapeutics
DNTH
+$6.79M

Top Sells

1
+$70M
2
+$20.5M
3
+$8.73M
4
AKBA icon
Akebia Therapeutics
AKBA
+$7.23M
5
EOLS icon
Evolus
EOLS
+$6.63M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SANA icon
26
Sana Biotechnology
SANA
$841M
$2.48M 1.04%
+700,000
ABSI icon
27
Absci
ABSI
$368M
$2.42M 1.01%
+796,438
PLRX icon
28
Pliant Therapeutics
PLRX
$81.7M
$1.26M 0.53%
850,000
SRRK icon
29
Scholar Rock
SRRK
$4.96B
– –
-61,607
ACLX icon
30
Arcellx
ACLX
$6.69B
– –
-100,000
AKBA icon
31
Akebia Therapeutics
AKBA
$375M
– –
-1,985,915
CAPR icon
32
Capricor Therapeutics
CAPR
$1.83B
– –
0
CNTA
33
Centessa Pharmaceuticals
CNTA
$4.17B
– –
-225,000
EOLS icon
34
Evolus
EOLS
$351M
– –
-720,118
HRMY icon
35
Harmony Biosciences
HRMY
$1.67B
– –
0
KALV icon
36
KalVista Pharmaceuticals
KALV
$922M
– –
-323,170
PMN icon
37
ProMIS Neurosciences
PMN
$43.2M
– –
-105,805
BBOT
38
BridgeBio Oncology
BBOT
$799M
– –
-29,381
1
2